April 2024
1. LI VW, Sahota J, Dev DK, Gill DD, et al
   A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une evaluation randomisee de MoodFX, un outil de sante en ligne centre sur le patient pour soutenir la mesure du resultat dans la depress
   Can J Psychiatry. 2024 Apr 11:7067437241245331. doi: 10.1177/07067437241245331.
   

   >> Share

   
   
2. WANG T, Gao C, Li J, Li L, et al
   Prediction of Early Antidepressant Efficacy in Patients with Major Depressive Disorder Based on Multidimensional Features of rs-fMRI and P11 Gene DNA Methylation: Prediction de l'efficacite precoce d'un antidepresseur chez des patients souffrant du tr
   Can J Psychiatry. 2024;69:264-274.
   

   >> Share

   
   February 2024
3. JALALI S, Liu L, Wang J, Kennedy SH, et al
   Factors Associated with Transition to Serious Mental Illness.
   Can J Psychiatry. 2024;69:79-88.
   

   >> Share

   
   
4. LAPOSA JM, Cameron D, Corace K, Quick N, et al
   A Rapid Access Brief Psychotherapy Intervention to Respond to Healthcare Workers in Ontario Whose Mental Health was Negatively Impacted During the COVID-19 Pandemic.
   Can J Psychiatry. 2024;69:89-99.
   

   >> Share

   
   December 2023
5. LAI KSP, Waxman R, Blumberger DM, Giacobbe P, et al
   Competencies for Repetitive Transcranial Magnetic Stimulation in Postgraduate Medical Education: Expert Consensus Using a Modified Delphi Process.
   Can J Psychiatry. 2023;68:916-924.
   

   >> Share

   
   November 2023
6. KHAN I, Chawla N
   Comments on "A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial".
   Can J Psychiatry. 2023 Nov 22:7067437231216175. doi: 10.1177/07067437231216175.
   

   >> Share

   
   
7. PINTO JV, Crippa JAS, Cereser KM, Vianna-Sulzbach MF, et al
   Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study.
   Can J Psychiatry. 2023 Nov 3:7067437231209650. doi: 10.1177/07067437231209650.
   

   >> Share

   
   October 2023
8. ISLAM F, Magarbeh L, Elsheikh SSM, Kloiber S, et al
   Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study.
   Can J Psychiatry. 2023 Oct 5:7067437231203433. doi: 10.1177/07067437231203433.
   

   >> Share

   
   September 2023
9. ANDREWS KL, Jamshidi L, Nisbet J, Brunet A, et al
   Potentially Psychologically Traumatic Event Exposure Histories of new Royal Canadian Mounted Police Cadets.
   Can J Psychiatry. 2023;68:663-681.
   

   >> Share

   
   August 2023
10. BASTIEN G, McAnulty C, Ledjiar O, Socias ME, et al
    Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.
    Can J Psychiatry. 2023;68:572-585.
    

    >> Share

    
    May 2023
11. TOURJMAN SV, Buck G, Jutras-Aswad D, Khullar A, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
    Can J Psychiatry. 2023;68:299-311.
    

    >> Share

    
    April 2023
12. ADHIKARI K, Racine N, Hetherington E, McDonald S, et al
    Women's Mental Health up to Eight Years after Childbirth and Associated Risk Factors: Longitudinal Findings from the All Our Families Cohort in Canada.
    Can J Psychiatry. 2023;68:269-282.
    

    >> Share

    
    
13. WOOD-ROSS C, Tran T, Milanovic M, Jokic R, et al
    Neurocognition and Depressive Symptoms have Unique Pathways to Predicting Different Domains of Functioning in Major Depressive Disorder.
    Can J Psychiatry. 2023;68:241-248.
    

    >> Share

    
    February 2023
14. ISHRAT HUSAIN M, Rodie DJ, Perivolaris A, Sanches M, et al
    A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial.
    Can J Psychiatry. 2023 Feb 28:7067437231156243. doi: 10.1177/07067437231156243.
    

    >> Share

    
    
15. HARKNESS KL, Chakrabarty T, Rizvi SJ, Mazurka R, et al
    The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report.
    Can J Psychiatry. 2023 Feb 13:7067437231156255. doi: 10.1177/07067437231156255.
    

    >> Share

    
    January 2023
16. GREEN JE, Berk M, Mohebbi M, Loughman A, et al
    Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.
    Can J Psychiatry. 2023 Jan 13:7067437221150508. doi: 10.1177/07067437221150508.
    

    >> Share

    
    
17. ROSENBLAT JD, Husain MI, Lee Y, McIntyre RS, et al
    The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
    Can J Psychiatry. 2023;68:5-21.
    

    >> Share

    
    November 2022
18. SLOMP C, Morris E, Edwards L, Hoens AM, et al
    Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
    Can J Psychiatry. 2022 Nov 28:7067437221140383. doi: 10.1177/07067437221140383.
    

    >> Share

    
    
19. KAHAWAGE P, Bullock B, Meyer D, Gottlieb J, et al
    Social Rhythm Disruption is Associated with Greater Depressive Symptoms in People with Mood Disorders: Findings from a Multinational Online Survey During COVID-19.
    Can J Psychiatry. 2022;67:831-840.
    

    >> Share

    
    August 2022
20. THATIKONDA NS, Vinod P, Balachander S, Bhaskarpillai B, et al
    Efficacy of Repetitive Transcranial Magnetic Stimulation on Comorbid Anxiety and Depression Symptoms in Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Sham-Controlled Trials.
    Can J Psychiatry. 2022 Aug 22:7067437221121112. doi: 10.1177/07067437221121112.
    

    >> Share

    
    May 2022
21. DO A, Li VW, Huang S, Michalak EE, et al
    Blue-Light Therapy for Seasonal and Non-Seasonal Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Can J Psychiatry. 2022 May 6:7067437221097903. doi: 10.1177/07067437221097903.
    

    >> Share

    
    
22. BONARDI O, Wang Y, Li K, Jiang X, et al
    Effects of COVID-19 Mental Health Interventions Among Children, Adolescents, and Adults Not Quarantined or Undergoing Treatment Due to COVID-19 Infection: A Systematic Review of Randomised Controlled Trials.
    Can J Psychiatry. 2022;67:336-350.
    

    >> Share

    
    
23. GOEGAN SA, Hasey GM, King JP, Losier BJ, et al
    Naturalistic Study on the Effects of Electroconvulsive Therapy (ECT) on Depressive Symptoms.
    Can J Psychiatry. 2022;67:351-360.
    

    >> Share

    
    April 2022
24. DIEP C, Bhat V, Wijeysundera DN, Clarke HA, et al
    The Association between Recent Cannabis Use and Suicidal Ideation in Adults: A Population-based Analysis of the NHANES from 2005 to 2018.
    Can J Psychiatry. 2022;67:259-267.
    

    >> Share

    
    March 2022
25. VASILIADIS HM, Lamoureux-Lamarche C, Grenier S, Roberge P, et al
    Minimally Adequate Treatment for Depression and Anxiety Associated With Mortality in Primary Care Older Adults.
    Can J Psychiatry. 2022 Mar 7:7067437221082883. doi: 10.1177/07067437221082883.
    

    >> Share

    
    
26. XI C, Liu Z, Zeng C, Tan W, et al
    The centrality of working memory networks in differentiating bipolar type I depression from unipolar depression: A task-fMRI study.
    Can J Psychiatry. 2022 Mar 4:7067437221078646. doi: 10.1177/07067437221078646.
    

    >> Share

    
    January 2022
27. VAN LIESHOUT RJ, Layton H, Savoy CD, Haber E, et al
    Public Health Nurse-delivered Group Cognitive Behavioural Therapy for Postpartum Depression: A Randomized Controlled Trial.
    Can J Psychiatry. 2022 Jan 21:7067437221074426. doi: 10.1177/07067437221074426.
    

    >> Share

    
    
28. BENOIT JRA, Dursun SM, Greiner R, Cao B, et al
    Using Machine Learning to Predict Remission in Patients With Major Depressive Disorder Treated With Desvenlafaxine.
    Can J Psychiatry. 2022;67:39-47.
    

    >> Share

    
    November 2021
29. SAREEN J, Bolton SL, Mota N, Afifi TO, et al
    Lifetime Prevalence and Comorbidity of Mental Disorders in the Two-wave 2002-2018 Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey (CAFVMHS): Prevalence et Comorbidite de Duree de vie Des Troubles Mentaux Dans l'Enquete de Sui
    Can J Psychiatry. 2021;66:951-960.
    

    >> Share

    
    
30. AFIFI TO, Sareen J, Taillieu T, Stewart-Tufescu A, et al
    Association of Child Maltreatment and Deployment-related Traumatic Experiences with Mental Disorders in Active Duty Service Members and Veterans of the Canadian Armed Forces: Association de la Maltraitance des Enfants et des Experiences Traumatisantes
    Can J Psychiatry. 2021;66:961-970.
    

    >> Share

    
    October 2021
31. SARRIS J, Marx W, Ashton MM, Ng CH, et al
    Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les medicaments a base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une me
    Can J Psychiatry. 2021;66:849-862.
    

    >> Share

    
    September 2021
32. BULLOCH A, Zulyniak S, Williams J, Bajgai J, et al
    Poor Mental Health during the COVD-19 Pandemic: Effect Modification by Age.
    Can J Psychiatry. 2021;66:827-829.
    

    >> Share

    
    
33. MCINERNEY SJ, Chakrabarty T, Maciukiewicz M, Frey BN, et al
    Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Pro
    Can J Psychiatry. 2021;66:798-806.
    

    >> Share

    
    June 2021
34. WONG SMY, Hui CLM, Wong CSM, Suen YN, et al
    Mental Health Risks after Repeated Exposure to Multiple Stressful Events during Ongoing Social Unrest and Pandemic in Hong Kong: The Role of Rumination: Risques pour la sante mentale apres une exposition repetee a de multiples evenements stressants d'
    Can J Psychiatry. 2021;66:577-585.
    

    >> Share

    
    
35. ZARATE CA JR
    Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder.
    Can J Psychiatry. 2021;66:537-539.
    

    >> Share

    
    April 2021
36. VAIDYAM AN, Linggonegoro D, Torous J
    Changes to the Psychiatric Chatbot Landscape: A Systematic Review of Conversational Agents in Serious Mental Illness: Changements du paysage psychiatrique des chatbots: une revue systematique des agents conversationnels dans la maladie mentale serieus
    Can J Psychiatry. 2021;66:339-348.
    

    >> Share

    
    March 2021
37. MORTON E, Michalak EE, Levitt A, Levitan RD, et al
    Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Can J Psychiatry. 2021;66:289-297.
    

    >> Share

    
    February 2021
38. SWAINSON J, McGirr A, Blier P, Brietzke E, et al
    The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Reseau Canadien Pour Les Traitements De L'humeur
    Can J Psychiatry. 2021;66:113-125.
    

    >> Share

    
    
39. BHARGAV PH, Reddy PV, Govindaraj R, Gulati K, et al
    Impact of a Course of Add-on Supervised Yoga on Cortical Inhibition in Major Depressive Disorder: A Randomized Controlled Trial.
    Can J Psychiatry. 2021;66:179-181.
    

    >> Share

    
    
40. BARTOLI F, Bachi B, Calabrese A, Moretti F, et al
    Cannabidiol for Mood Disorders: A Call for More Research.
    Can J Psychiatry. 2021;66:182-183.
    

    >> Share

    
    January 2021
41. ENNS MW, Mota N, Afifi TO, Bolton SL, et al
    Course and Predictors of Major Depressive Disorder in the Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey: Cours et Predicteurs du Trouble de Depression Majeure Dans l'Enquete de Suivi Sur la Sante Mentale Aupres Des Membres
    Can J Psychiatry. 2021 Jan 7:706743720984677. doi: 10.1177/0706743720984677.
    

    >> Share

    
    
42. LEMIEUX R, Garon-Bissonnette J, Loiselle M, Martel E, et al
    
    Can J Psychiatry. 2021;66:34-42.
    

    >> Share

    
    
43. SMITH PM, Oudyk J, Potter G, Mustard C, et al
    The Association between the Perceived Adequacy of Workplace Infection Control Procedures and Personal Protective Equipment with Mental Health Symptoms: A Cross-sectional Survey of Canadian Health-care Workers during the COVID-19 Pandemic: L'associatio
    Can J Psychiatry. 2021;66:17-24.
    

    >> Share

    
    
44. MURRAY G, Gottlieb J, Swartz HA
    Maintaining Daily Routines to Stabilize Mood: Theory, Data, and Potential Intervention for Circadian Consequences of COVID-19.
    Can J Psychiatry. 2021;66:9-13.
    

    >> Share

    
    November 2020
45. LI A, Rosella LC, Kurdyak P, Wodchis WP, et al
    Depression as a Risk Factor for Physical Illness and Multimorbidity in a Cohort with No Prior Comorbidity: La Depression Comme Facteur de Risque de Maladie Physique et de Multimorbidite Dans Une Cohorte Sans Comorbidite Anterieure.
    Can J Psychiatry. 2020 Nov 26:706743720974832. doi: 10.1177/0706743720974832.
    

    >> Share

    
    
46. BAHJI A, Ermacora D, Stephenson C, Hawken ER, et al
    Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis: Efficacite Et Tolerabilite Comparatives Des Pharmacotherapies D'appoint Pour La Depression Bipolaire Aig
    Can J Psychiatry. 2020 Nov 11:706743720970857. doi: 10.1177/0706743720970857.
    

    >> Share

    
    October 2020
47. THOMBS BD, Levis B, Lyubenova A, Neupane D, et al
    Overestimation of Postpartum Depression Prevalence Based on a 5-item Version of the EPDS: Systematic Review and Individual Participant Data Meta-analysis.
    Can J Psychiatry. 2020 Oct 26:706743720934959. doi: 10.1177/0706743720934959.
    

    >> Share

    
    
48. SCHMITZ N, Holley P, Meng X, Fish L, et al
    COVID-19 and Depressive Symptoms: A Community-based Study in Quebec, Canada.
    Can J Psychiatry. 2020;65:733-735.
    

    >> Share

    
    
49. ZHOU L, Xie RH, Yang X, Zhang S, et al
    Feasibility and Preliminary Results of Effectiveness of Social Media-based Intervention on the Psychological Well-being of Suspected COVID-19 Cases during Quarantine.
    Can J Psychiatry. 2020;65:736-738.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share